INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $885 | -22.5% | 28 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,142 | +9.4% | 28 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,044 | +6.9% | 28 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $977 | -51.2% | 28 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $2,000 | +100.0% | 28 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $1,000 | -50.0% | 28 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -33.3% | 28 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | +200.0% | 28 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $1,000 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |